Ciruelos, E., Vidal, M., Martínez de Dueñas, E. et al. Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain. Clin Transl Oncol 20, 753–760 (2018). https://doi.org/10.1007/s12094-017-1784-1

Acceso a PubMed

Comprar el archivo PDF